Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management. Carrá A, Macías Islas M A, Tarulla A, Bichuetti D B, Finkelsztejn A, Fragoso Y D, Árcega-Revilla R, Rodríguez C C, Durán J C, Bonitto J G, et al. Expert Rev Neurother. 2015 Apr 30:1-4. PMID: 25924772. Abstract CommentRecommendBookmarkWatch